Filter on [TOPICS=Adherence, frailty, integrated care and multi-chronic conditions]

3rd Health Programme (2014-2020)
Empowering pharmacists to improve health care for oral chemotherapy patients: Establishment of a European best-practice model [EPIC]
Oncology is undoubtedly currently the fastest developing area of healthcare. More or less every month new drugs come to the market; many of them are formulations for oral administration. This means th...
Oncology is undoubtedly currently the fastest developing area of healthcare. More or less every month new drugs come to the market; many of them are formulations for oral administration. This means that the complex treatment of often co-morbid oncology patients is moving from a supervised hospital setting to the patient’s home and dispensing of potent oral anticancer drugs to general community pharmacies. Pharmacists in such pharmacies are not specialized in care for oncology patients, since the curriculum of pharmacy studies includes few oncology-related topics.
Our purpose is to empower pharmacists to improve therapy-related outcomes and patient safety by lending support for the pharmaceutical counselling related to the dispensing of oral anticancer drugs. By doing so in selected member countries, we will create a best-practice model for the EU.
To this end, we will first survey the current situation and problems at dispensing of oral anticancer drugs in the EU. Based on the results we will design optimal post-graduate education for pharmacists about oncology topics and develop IT-tools that assist the pharmaceutical counselling process. This will allow the pharmacist quick access to essential information on oral oncology drugs including important advice for patients as well as useful service options like the preparation of treatment plans for the patient. By evaluating user satisfaction with the IT-tools and educational programme and subsequent implementation of improvements, we establish a ‘learning system’. This system will be put to effect in the participating partner countries and later made available for implementation in other EU-countries.
These measures will improve patients’ self-efficacy regarding his or her disease and therapy and, consequently, will enhance adherence.
Start date: 01/05/2015 - End date: 30/04/2018

Call: Call for Proposals for Projects 2014
3rd Health Programme (2014-2020)
Frailty management Optimisation through EIP AHA Commitments and Utilisation of Stakeholders input [FOCUS]
Our purpose is to critically reduce the burden of frailty in Europe by assisting those partners within the European Innovation Partnership for Active Healthy Ageing (EIPAHA) with commitments focusing ...
Our purpose is to critically reduce the burden of frailty in Europe by assisting those partners within the European Innovation Partnership for Active Healthy Ageing (EIPAHA) with commitments focusing on early diagnosis/screening and/or management of frailty to achieve scalability. We have selected EIPAHA because it constitutes a critical instrument for the EU and because it composes the widest representation of initiatives about frailty in Europe.
Our project offers both a service and a network. The service consists of evidence-based guidelines to critically help the selected group of partners to satisfactorily achieve their goals. The network intends to prolong the service in the long term.
To achieve that purpose (WP4) we will define the roadmap, in that we will i) describe the state of art (review of the scientific literature), ii) get a picture of the status of the affected commitments within EIPAHA (barriers, enablers, etc.), and iii) obtain information of the needs of stakeholders. With this real-world landscape in hand, WP5 will define indicators and use a scientifically sound method, comparative effectiveness research, to draw conclusions regarding the most adequate and customized approach to assist commitments in achieving success. Inequalities, cultural conditions or cross-border issues will be considered as representative of the diversity in Europe. Guidelines and toolkits will be issued with the perspective of sustainability. WP6 will constitute the “Platform for Knowledge Exchange” (PKE), which will both facilitate and perpetuate exchange between partners and stakeholders to achieve synergies and guide progression. PKE will act as a repository and as an instrument for dissemination too. WP7 will be a practical test to verify the usability and performance of guidelines in real EIPAHA commitments.
Relevance derives from the wide prevalence of frailty in Europe, consistently the focus throughout the work programme.

Start date: 01/05/2015 - End date: 30/04/2018

Call: Call for Proposals for Projects 2014
3rd Health Programme (2014-2020)
FRAILTOOLS: A comprehensive validation of tools to screen and diagnose frailty in different clinical and social settings to provide instruments for integrated care in older adults [FRAILTOOLS]
There is a proved strong evidence of the usefulness of frailty as a predictive factor of relevant undesired outcomes in populations of older adults. Several studies have been published showing the uti...
There is a proved strong evidence of the usefulness of frailty as a predictive factor of relevant undesired outcomes in populations of older adults. Several studies have been published showing the utility of the concept in improving the prognostic accuracy and the prediction of different risks (hospitalization, surgical and non-surgical complications, length of stay, death, incident disability, etc) in emergency departments, cardiac surgery, surgical patients and in patients with cardiovascular disease. These studies have placed the focus in assessing population risk, while the validation process for these instruments as diagnostic or screening tools has been usually neglected.FRAILTOOLS aims to assess the usefulness as screening and diagnosis tools of some selected instruments to detect frailty in both clinical (Hospital and Primary Care) and social (nursing homes) settings, providing diagnostic algorithms clinically sound. Target groups are all of those older adults at risk for frailty (pre-frail) plus those that are frail and are at risk for developing disability. According to the published prevalence of these two conditions, the target population concerned by this project represent around 40-50% of older people older than 65 and 60-70% of people older than 75. Once determined the best tools of screening and diagnosis in different settings of care, we will reach conclusions for this people wherever the level of care they need and currently use. The benefit will expand to the Health Systems and Social Care as it will provide validated instruments that are necessary to provide an appropriate care for older adults by means of a comprehensive, continued, coordinated and integrated care.FRAILTOOLS consortium involves 6 of the most renowned partners in research on ageing and frailty from Spain, UK, Italy, France and Poland, plus the support of a number of highly relevant collaborating stakeholders fully committed with the project.
Start date: 01/05/2015 - End date: 31/12/2018

Call: Call for Proposals for Projects 2014